김선화 (한국과학기술연구원(KIST))님 | 한빛사연구자 > 한빛사

한국과학기술연구원(KIST)

CV File

바이오센싱 및 나노바이오물질

최종업데이트 2024.03.25.

Repositioning of Ertiprotafib via supramolecular assembly enables biomarker-guided therapy for acute kidney injury
- J. Nanobiotechnol., 10 April 2026 | https://doi.org/10.1186/s12951-026-04357-7
- 2026-04
- 바이오·의료융합
- 한빛사논문
Drug repositioning of mesalamine via supramolecular nanoassembly for the treatment of drug-induced acute liver failure
- Theranostics, 2025; 15(3):1122-1134 | https://www.thno.org/v15p1122
- 2025-01
- 바이오·의료융합
- 한빛사논문
Dual-Action Protein-siRNA Conjugates for Targeted Disruption of CD47-Signal Regulatory Protein α Axis in Cancer Therapy
- ACS Nano, Aug 08 2024, | https://doi.org/10.1021/acsnano.4c06471
- 2024-08
- 바이오·의료융합
- 한빛사논문
Targeted delivery of anti-miRNA21 sensitizes PD-L1high tumor to immunotherapy by promoting immunogenic cell death
- Theranostics, 2024 Jun 17;14(10):3777-3792 | https://doi.org/10.7150/thno.97755
- 2024-06
- 바이오·의료융합
- 한빛사논문
Mucoadhesive Mesalamine Prodrug Nanoassemblies to Target Intestinal Macrophages for the Treatment of Inflammatory Bowel Disease
- ACS Nano, June 12, 2024 | https://doi.org/10.1021/acsnano.4c05544
- 2024-06
- 바이오·의료융합
- 한빛사논문
Design of PD-L1-Targeted Lipid Nanoparticles to Turn on PTEN for Efficient Cancer Therapy
- Adv. Sci., Mar 23 2024, | https://doi.org/10.1002/advs.202309917
- 2024-03
- 바이오·의료융합
- 한빛사논문
Oral TNF-α siRNA delivery via milk-derived exosomes for effective treatment of inflammatory bowel disease
- Bioact. Mater., Available online 22 December 2023 | https://doi.org/10.1016/j.bioactmat.2023.12.010
- 2023-12
- 바이오·의료융합
- 한빛사논문
Post-insertion technique to introduce targeting moieties in milk exosomes for targeted drug delivery
- Biomater. Res., Nov 29 2023, 27 (1) | https://doi.org/10.1186/s40824-023-00456-w
- 2023-11
- 바이오·의료융합
- 한빛사논문
RNAi therapies: Expanding applications for extrahepatic diseases and overcoming delivery challenges.
- Adv. Drug Deliv. Rev., Volume 201, October 2023, 115073 | https://doi.org/10.1016/j.addr.2023.115073
- 2023-10
- 바이오·의료융합
- 한빛사논문
Exosome-guided direct reprogramming of tumor-associated macrophages from protumorigenic to antitumorigenic to fight cancer
- Bioact. Mater., Volume 25, July 2023 | https://doi.org/10.1016/j.bioactmat.2022.07.021
- 2023-07
- 바이오·의료융합
- 한빛사논문

저자논문

저자논문

저자논문

저자논문

CV 열람하기

연락처 보기